Arrowhead Pharmaceuticals, Inc. (ARWR) Cash Flow Statement
Arrowhead Pharmaceuticals, Inc. (ARWR) generated -$59.1M of operating cash flow over the twelve months to 2026-06-30, spent $16.1M on capital expenditure and had free cash flow of -$75.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ARWRArrowhead Pharmaceuticals, Inc.Follow ARWR — free
—
Price chart with a free account
- Market cap
- 8.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 23 Nov, in 30 days
| Line | FY2011 Sep 11 | FY2012 Sep 12 | FY2013 Sep 13 | FY2014 Sep 14 | FY2015 Sep 15 | FY2016 Sep 16 | FY2017 Sep 17 | FY2018 Sep 18 | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.01 | -0.02 | -0.02 | -0.04 | -0.07 | -0.06 | -0.02 | -0.05 | 0.17 | -0.10 | 0.17 | -0.14 | -0.15 | -0.46 | 0.18 | -0.06 | |
| Capital expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 | 0.05 | 0.18 | 0.14 | 0.02 | -0.02 | |
| Free cash flow | -0.01 | -0.02 | -0.02 | -0.04 | -0.07 | -0.07 | -0.03 | -0.05 | 0.16 | -0.11 | 0.15 | -0.19 | -0.33 | -0.60 | 0.16 | -0.08 | |
| Stock-based compensation | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.08 | 0.12 | 0.08 | 0.07 | 0.06 | — |
USD billions · SEC XBRL
Arrowhead Pharmaceuticals, Inc. — questions
- What is Arrowhead Pharmaceuticals, Inc.'s operating cash flow?
- -$59.1M over the twelve months to 2026-06-30.
- How much does Arrowhead Pharmaceuticals, Inc. spend on capital expenditure?
- $16.1M over the twelve months to 2026-06-30.
- What is Arrowhead Pharmaceuticals, Inc.'s free cash flow?
- -$75.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Arrowhead Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.